Acadia Healthcare Company, Inc. (FRA:7RA)

Acadia Healthcare Company Statistics

Total Valuation

FRA:7RA has a market cap or net worth of EUR 1.34 billion. The enterprise value is 3.49 billion.

Market Cap	1.34B
Enterprise Value	3.49B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	92.26M
Shares Outstanding	n/a
Shares Change (YoY)	-0.53%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	1.83%
Owned by Institutions (%)	118.55%
Float	83.33M

Valuation Ratios

The trailing PE ratio is 14.61 and the forward PE ratio is 7.67.

PE Ratio	14.61
Forward PE	7.67
PS Ratio	0.48
PB Ratio	0.48
P/TBV Ratio	2.09
P/FCF Ratio	n/a
P/OCF Ratio	4.68
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.01, with an EV/FCF ratio of -11.79.

EV / Earnings	38.12
EV / Sales	1.24
EV / EBITDA	6.01
EV / EBIT	9.14
EV / FCF	-11.79

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.74.

Current Ratio	1.44
Quick Ratio	1.20
Debt / Equity	0.74
Debt / EBITDA	3.63
Debt / FCF	-7.06
Interest Coverage	3.39

Financial Efficiency

Return on equity (ROE) is 3.69% and return on invested capital (ROIC) is 5.08%.

Return on Equity (ROE)	3.69%
Return on Assets (ROA)	4.52%
Return on Invested Capital (ROIC)	5.08%
Return on Capital Employed (ROCE)	7.53%
Revenue Per Employee	124,551
Profits Per Employee	4,095
Employee Count	25,500
Asset Turnover	0.53
Inventory Turnover	323.32

Taxes

In the past 12 months, FRA:7RA has paid 19.28 million in taxes.

Income Tax	19.28M
Effective Tax Rate	15.99%

Stock Price Statistics

The stock price has decreased by -61.78% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-61.78%
50-Day Moving Average	18.28
200-Day Moving Average	20.93
Relative Strength Index (RSI)	42.82
Average Volume (20 Days)	10

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.08

Income Statement

In the last 12 months, FRA:7RA had revenue of EUR 2.78 billion and earned 91.50 million in profits. Earnings per share was 1.01.

Revenue	2.78B
Gross Profit	1.16B
Operating Income	378.24M
Pretax Income	120.57M
Net Income	91.50M
EBITDA	534.24M
EBIT	378.24M
Earnings Per Share (EPS)	1.01

Balance Sheet

The company has 101.16 million in cash and 2.09 billion in debt, giving a net cash position of -1.99 billion.

Cash & Cash Equivalents	101.16M
Total Debt	2.09B
Net Cash	-1.99B
Net Cash Per Share	n/a
Equity (Book Value)	2.80B
Book Value Per Share	29.41
Working Capital	196.06M

Cash Flow

In the last 12 months, operating cash flow was 285.43 million and capital expenditures -581.36 million, giving a free cash flow of -295.93 million.

Operating Cash Flow	285.43M
Capital Expenditures	-581.36M
Free Cash Flow	-295.93M
FCF Per Share	n/a

Margins

Gross margin is 41.78%, with operating and profit margins of 13.59% and 3.29%.

Gross Margin	41.78%
Operating Margin	13.59%
Pretax Margin	4.33%
Profit Margin	3.29%
EBITDA Margin	19.19%
EBIT Margin	13.59%
FCF Margin	n/a

Dividends & Yields

FRA:7RA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.53%
Shareholder Yield	0.53%
Earnings Yield	6.85%
FCF Yield	-22.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:7RA has an Altman Z-Score of 1.45 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.45
Piotroski F-Score	5